Latest Posts

05 Oct 2018

AUSTRALASIAN COLLEGE OF PHLEBOLOGY ABSTRACT DEADLINE JAN. 7; KEYNOTERS NAMED

  300-word abstracts for the 20th Annual Scientific Meeting of the Australasian College of Phlebology in Cairns, Queensland from May 5-7, 2019 are being accepted for either an oral presentation or poster presentation until Jan. 7, 2019, and notification of accepted abstracts will be made by Jan. 21. Research abstracts

0
05 Oct 2018

CYNTHIA SHAPIRO, FNP-C JOINS AMERICAN VEIN AT HIGHLANDS RANCH CLINIC

  Cynthia Shapiro, FNP-C, has joined American Vein & Vascular Institute’s Highlands Ranch clinic as a a board-certified nurse practitioner. Shapiro has 25 years of career experience in the healthcare and medical industries. American Vein & Vascular Institute is an award-winning network of vein and arterial diagnosis and treatment centers

0
05 Oct 2018

FUJIFILM SONOSOFT SOLIDIFIES WORKFLOW WITH SYNCHRONICITY

  FUJIFILM SonoSite Inc., developers of point-of-care ultrasound solutions, has entered the medical informatics space with the launch of SonoSite Synchronicity, designed to optimize workflows by integrating with existing data management systems and enabling the use of current user login credentials. The software can be implemented across multiple departments in an organization to standardize operations. In

0
05 Oct 2018

VIVA THE VEINS! THE VEINS, A TWO-DAY COURSE IN VIVA 2018, OFFERS INTERDISCIPLINARY VASCULAR EDUCATION

For the past 16 years, world-renowned specialists from across the vascular intervention and medicine spectrum have converged in Las Vegas to make VIVA (Vascular InterVentional Advances) a growing educational event for the dedicated vascular specialist. This year, VIVA 2018 will be Nov. 5-8 at the Wynn Las Vegas. The VEINS

0
04 Oct 2018

RA MEDICAL’S IPO DELIVERS $86 MILLION

Ra Medical announced Oct. 3 that its initial public offering brought in more than $86 million by the time it closed, including an underwriter’s option that added some $10 million to the take. The Dabra catheter is designed to destroy arteriosclerotic blockages with radiation ablation, which the company touts as having

0
SHARE

Home